FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

16699711000001100: Ondansetron 8mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Apr 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58689801000001113 Ondansetron 8mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58689901000001119 Ondansetron 8mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 8mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Is a Ondansetron 8mg tablets true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Is a Ondansetron 8mg tablets false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Is a Product containing precisely ondansetron 8 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has active ingredient Ondansetron false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has specific active ingredient Ondansetron hydrochloride true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Pfizer Ltd) Has basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron 8mg tablets (Pfizer Ltd) 10 tablet Has AMP True Ondansetron 8mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start